{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:04:54Z","timestamp":1773176694033,"version":"3.50.1"},"reference-count":52,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1699,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> TV3326, (<jats:italic>N<\/jats:italic>\u2010propargyl\u2010(3R)\u2010aminoindan\u20105\u2010yl\u2010ethyl, methyl carbamate) was prepared in order to combine the neuroprotective effects of rasagiline, a selective inhibitor of monoamine oxidase (MAO)\u2010B with the cholinesterase (ChE) inhibitory activity of rivastigmine as a potential treatment for Alzheimer's disease. The study reported here examined the neuropotective effects of TV3326 against various insults <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. TV3326 caused a dose related (10\u2013500 \u03bcM) reduction in death induced in NGF differentiated rat pheochromocytoma (PC12) cells by 3\u20134 hour exposure to oxygen\u2010glucose deprivation. A single sc injection of TV3326 given five minutes after closed head injury in mice significantly reduced the cerebral edema, and accelerated the recovery of motor function and spatial memory several days later. Unilateral icv injection of streptozotocin (STZ) 1.5 mg in rats, caused specific damage to myelinated neurones in the fornix and corpus callosum accompanied by microgliosis. Three bilateral injections of STZ, 0.25 mg each, caused more widespread damage, and a marked impairment in spatial memory. Chronic oral treatment with TV3326 (75 \u03bcmols\/kg) reduced the neuronal damage and microgliosis and almost completely prevented the memory impairment. The neuroprotective effect in PC12 cells may be due to a combination of ChE inhibition and antiapoptotic activity. The latter does not result from ChE inhibition. It is associated with the presence of the propargyl group, since it occurs with other propargylamines that do not inhibit MAO, but not with drugs that inhibit only ChE.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb03622.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T22:20:13Z","timestamp":1279664413000},"page":"148-161","source":"Crossref","is-referenced-by-count":69,"title":["Neuroprotective Effects of Novel Cholinesterase Inhibitors Derived from Rasagiline as Potential Anti\u2010Alzheimer Drugs"],"prefix":"10.1111","volume":"939","author":[{"given":"MARTA","family":"WEINSTOCK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NATANJA","family":"KIRSCHBAUM\u2010SLAGER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PHILIP","family":"LAZAROVICI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CORINA","family":"BEJAR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOUSSA B.H.","family":"YOUDIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHAI","family":"SHOHAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7901908"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90018-3"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb09439.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.63062179.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199408030-00001"},{"key":"e_1_2_6_7_2","first-page":"321","article-title":"Microglia, an in vivo source of reactive oxygen species in the brain","volume":"59","author":"Colton C.A.","year":"1993","journal-title":"Adv. Neurol."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6338589"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199912040-00005"},{"key":"e_1_2_6_10_2","first-page":"1216","article-title":"A controlled trial of selegiline, alpha\u2010tocopherol, or both as treatment for Alzheimer's disease","volume":"336","author":"Sano M.","year":"1997","journal-title":"The Alzheimer's Disease Cooperative Study. New Eng. J. Med."},{"key":"e_1_2_6_11_2","first-page":"234","article-title":"Selegiline in the treatment of Alzheimer's disease: a long\u2010term randomized placebo\u2010controlled trial","volume":"24","author":"Filip V.","year":"1999","journal-title":"Czech and Slovak Senile Dementia of Alzheimer Type Study Group. J. Psychiatry Neurosci."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1996.tb39078.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.10.1883"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-6499-0_13"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6_Suppl_3.171S"},{"key":"e_1_2_6_16_2","first-page":"95","article-title":"Pharmacology and neuroprotective properties of rasagiline","volume":"48","author":"Finberg J.P.M","year":"1996","journal-title":"J. Neural Transm. Suppl."},{"key":"e_1_2_6_17_2","first-page":"703","article-title":"Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor","volume":"9","author":"Finberg J.P.M.","year":"1998","journal-title":"Neuro-Report"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19991101)58:3<456::AID-JNR12>3.0.CO;2-S"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00929-7"},{"key":"e_1_2_6_20_2","first-page":"S45","article-title":"Neuroprotective properties of the antiparkinson drug rasagiline and its optical S\u2010isomer","volume":"54","author":"Youdim M.B.H.","year":"1999","journal-title":"Neurosci. Letts. Suppl."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<216::AID-DDR4>3.0.CO;2-Z"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.119.6.1669"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19990615)56:6<620::AID-JNR8>3.0.CO;2-F"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199805110-00050"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(99)00695-3"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.63041572.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/neu.1998.15.231","article-title":"Rivastigmine, a brain\u2010selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed\u2010head injury in the mouse","volume":"15","author":"Chen Y.","year":"1998","journal-title":"J. Neurotrauma."},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0736-5748(94)90053-1"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490310310"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)90284-4"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","unstructured":"M\u00fbller D. K. Plaschke & S. Hoyer. 1995. Intracerebroventricular injection of streptozotocin: an animal model for sporadic Alzheimer's disease?.InAlzheimer's and Parkinson's Diseases. I. Hanin et al. Eds.: 389\u2013390. Plenum Press New York.","DOI":"10.1007\/978-1-4757-9145-7_58"},{"key":"e_1_2_6_32_2","first-page":"265","article-title":"Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats","volume":"102","author":"Bastar I.","year":"1998","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(99)00012-X"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.1999.0254"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(61)90145-9"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.1996.13.557"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00643-3"},{"key":"e_1_2_6_38_2","unstructured":"Morris R.G.M. 1983. An attempt to dissociate \u201cspatial\u2010mapping\u201d and \u201cworking memory\u201d theories of hippocampal function.InThe Neurobiology of the Hippocampus. W. Siefert Ed.: 405\u2013432. Academic Press London."},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00294239"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6622"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(95)00066-N"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1999.tb00215.x"},{"key":"e_1_2_6_43_2","first-page":"63","article-title":"Is Alzheimer's a disease of oxidative stress","volume":"1","author":"Smith M.A.","year":"1996","journal-title":"Alzheimer's Dis. Rev."},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(86)90209-0"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91886-5"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(00)01088-0"},{"key":"e_1_2_6_47_2","unstructured":"Noai M. W. Maruyama M.B.H. Youdim et al.2001. Anti\u2010apoptotic function of propargylamine series of monoamine oxidase inhibitors. J. Pharm. Pharmacol In press."},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.1994.11.379"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.1996.13.457"},{"key":"e_1_2_6_50_2","first-page":"1229","article-title":"Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS\u20101","volume":"39","author":"Saini K.S.","year":"1996","journal-title":"Biochem. Mol. Biol. Int."},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007020050130"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(98)00158-2"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1037\/0735-7044.112.5.1199"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb03622.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03622.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T12:54:36Z","timestamp":1695646476000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb03622.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb03622.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03622.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}